Nicholas McGranahan

Molecular Biology · 2013–2023

A researcher in the Science corpus: 17 papers; trusts 18 researchers and is trusted by 6 researchers here, as inferred from the citation graph.

Subfields

Molecular Biology — 276 citations into it; #6,697 of 17,773 by trust here, #2,475 by citations
Cancer Research — 268 citations into it; #472 of 1,780 by trust here, #228 by citations
Oncology — 223 citations into it; #636 of 1,698 by trust here, #263 by citations
Genetics — 120 citations into it
Immunology — 103 citations into it
Radiology, Nuclear Medicine and Imaging — 22 citations into it
Artificial Intelligence — 13 citations into it

Whom Nicholas McGranahan trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

Who trusts Nicholas McGranahan overall

Papers from Nicholas McGranahan's perspective

Ordered by how strongly the researchers Nicholas McGranahan trusts endorse each paper. Same corpus, a different order for every researcher.

Discovery and saturation analysis of cancer genes across 21 tumor types (Nature)
Tumour evolution inferred by single-cell sequencing (Nature)
Absolute quantification of somatic DNA alterations in human cancer (Nature Biotechnology)
Hallmarks of cancer: the next generation. (Cell)
Mining Exomic Sequencing Data to Identify Mutated Antigens Recognized by Adoptively Transferred Tumor-reactive T cells (Nature Medicine)
Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma (New England Journal of Medicine)
Genetic basis for clinical response to CTLA-4 blockade in melanoma. (New England Journal of Medicine)
The DNA damage response and cancer therapy (Nature)
An APOBEC Cytidine Deaminase Mutagenesis Pattern is Widespread in Human Cancers (Nature Genetics)
Pan-cancer patterns of somatic copy-number alteration (Nature Genetics)

Their papers

Clonal status of actionable driver events and the timing of mutational processes in cancer evolution (2015) — 630 citations
The causes and consequences of genetic heterogeneity in cancer evolution (2013) — 2,128 citations
Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing (2014) — 1,192 citations
Spatial and temporal diversity in genomic instability processes defines lung cancer evolution (2014) — 1,056 citations
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future. (2017) — 2,488 citations
deconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution (2016) — 1,016 citations
Biological and therapeutic impact of intratumor heterogeneity in cancer evolution. (2015) — 1,041 citations
Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution (2017) — 1,156 citations
Chromosomal instability drives metastasis through a cytosolic DNA response (2018) — 1,367 citations
Lung adenocarcinoma promotion by air pollutants (2023) — 655 citations
Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition (2021) — 716 citations
Neoantigen directed immune escape in lung cancer evolution (2019) — 783 citations
Genomic features of response to combination immunotherapy in patients with advanced non-small cell lung cancer (2018) — 921 citations
Tracking the Evolution of Non‐Small‐Cell Lung Cancer (2017) — 2,016 citations
Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis. (2017) — 782 citations
Phylogenetic ctDNA analysis depicts early stage lung cancer evolution (2017) — 1,635 citations
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade (2016) — 2,796 citations